Daily as of 3 Nov 16:00 ET
- Price
- above both $601.32 vs 50 $530.53 / 200 $532.84
- Projection
- ๐จGolden cross projected in 3 bars
- Test
- No active test
- Last cross
- ๐Death cross 10 Sep 2026 ยท projected 21 bars out
United Therapeutics (UTHR) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2017.
Right now the daily is the chart to watch. The 50 SMA has sat below the 200 since Sep 2026, but the two have been closing on each other and a golden cross is projected within 10 bars. Price sits above the 50 and the 200 on the daily, the weekly and the 4-hour.
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 22 Oct 2026 | ๐จGolden | 4-hour | 30 bars out | Not tested |
| 10 Sep 2026 | ๐Death moderate | daily | 21 bars out | Not tested |
| 10 Jul 2026 | ๐Death | 4-hour | 20 bars out | 2 bar cross test |
| 18 Sep 2025 | ๐จGolden steep | daily | 14 bars out | Not tested |
| 18 Aug 2025 | ๐จGolden | 4-hour | 19 bars out | โ |
Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.